Spaltudaq Corporation
1616 Easlake Avenue E
Seattle
Washington
98102
United States
3 articles about Spaltudaq Corporation
-
Spaltudaq Corporation Announces Identification of Broadly and Potently Neutralizing Human HIV Antibodies and Change of Company Name to Theraclone Sciences, Inc.
3/30/2009
-
Spaltudaq Corp. Names New Senior Executives
5/23/2007
-
Spaltudaq Corp. Raises $29 Million; Second Accelerator Company to Complete Series B Financing
3/19/2007